Subretinal Stargardt Gene Therapy Treatment Well-Tolerated
Gene therapy did not cause any adverse visual changes, according to the report.
Erin Boyle
Erin Boyle is a medical writer and editor with more than 15 years’ experience writing and reporting on a variety of topics, including oncology, immunology, neurology. For more than a decade of that time, she’s specialized in ophthalmology, first as a staff writer and managing editor (of the European and Asia-Pacific editions) at Ocular Surgery News, then as a senior staff writer and editor at EyeWorld, the official publication of the American Society of Cataract and Refractive Surgery. She’s traveled to ophthalmology conferences around the world, writing daily news and follow-up pieces for ophthalmologists and savvy patients.
